JASPER THERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)
JASPER THERAPEUTICS, INC. (JSPR) reported Basic Shares Outstanding (Weighted Average) of 28.70 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- JASPER THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 28.70M shares, a 87.15% increase year-over-year.
- JASPER THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 28.67M shares, a 90.86% increase year-over-year.
- JASPER THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 28.77M shares, a 91.64% increase year-over-year.
- JASPER THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 16.64M shares, a 10.90% increase year-over-year.
- JASPER THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 19.17M shares, a 31.42% increase from fiscal 2024.
- JASPER THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 14.58M shares, a 39.71% increase from fiscal 2023.
- JASPER THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 10.44M shares, a 186.15% increase from fiscal 2022.
- JASPER THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 3.65M shares, a 67.98% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 28.70M shares 10-Q · filed 2026-08-14 | 28.68M shares 10-Q · filed 2026-08-14 | 28.71M shares derived: average of 3 quarters · filed 2026-08-14 | 25.69M shares derived: average of 4 quarters · filed 2026-08-14 | |||||
| 2026-03-31 | 28.67M shares 10-Q · filed 2026-05-14 | 28.72M shares derived: average of 2 quarters · filed 2026-05-14 | 24.69M shares derived: average of 3 quarters · filed 2026-05-14 | 22.35M shares derived: average of 4 quarters · filed 2026-08-14 | |||||
| 2025-12-31 | 28.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 22.70M shares derived: average of 2 quarters · filed 2026-03-30 | 20.25M shares derived: average of 3 quarters · filed 2026-08-14 | 19.17M shares 10-K · filed 2026-03-30 | |||||
| 2025-09-30 | 16.64M shares 10-Q · filed 2025-11-10 | 15.98M shares derived: average of 2 quarters · filed 2026-08-14 | 15.97M shares 10-Q · filed 2025-11-10 | 15.50M shares derived: average of 4 quarters · filed 2026-08-14 | |||||
| 2025-06-30 | 15.33M shares 10-Q · filed 2026-08-14 | 15.18M shares 10-Q · filed 2026-08-14 | 15.12M shares derived: average of 3 quarters · filed 2026-08-14 | 15.09M shares derived: average of 4 quarters · filed 2026-08-14 | |||||
| 2025-03-31 | 15.02M shares 10-Q · filed 2026-05-14 | 15.02M shares derived: average of 2 quarters · filed 2026-05-14 | 15.01M shares derived: average of 3 quarters · filed 2026-05-14 | 15.01M shares derived: average of 4 quarters · filed 2026-05-14 | |||||
| 2024-12-31 | 15.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 15.01M shares derived: average of 2 quarters · filed 2026-03-30 | 15.00M shares derived: average of 3 quarters · filed 2026-03-30 | 14.58M shares 10-K · filed 2026-03-30 | |||||
| 2024-09-30 | 15.00M shares 10-Q · filed 2025-11-10 | 14.99M shares derived: average of 2 quarters · filed 2025-11-10 | 14.44M shares 10-Q · filed 2025-11-10 | 13.59M shares derived: average of 4 quarters · filed 2025-11-10 | |||||
| 2024-06-30 | 14.99M shares 10-Q · filed 2025-08-13 | 14.16M shares 10-Q · filed 2025-08-13 | 13.12M shares derived: average of 3 quarters · filed 2025-08-13 | 12.59M shares derived: average of 4 quarters · filed 2025-08-13 | |||||
| 2024-03-31 | 13.33M shares 10-Q · filed 2025-05-12 | 12.19M shares derived: average of 2 quarters · filed 2025-05-12 | 11.79M shares derived: average of 3 quarters · filed 2025-05-12 | 11.57M shares derived: average of 4 quarters · filed 2025-05-12 | |||||
| 2023-12-31 | 11.05M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | 11.01M shares derived: average of 2 quarters · filed 2025-02-28 | 10.98M shares derived: average of 3 quarters · filed 2025-02-28 | 10.44M shares 10-K · filed 2025-02-28 | |||||
| 2023-09-30 | 10.23M shares 10-Q · filed 2024-11-07 | 10.97M shares 10-Q · filed 2024-11-07 | 109.72M shares 10-Q · filed 2023-11-09 | 10.95M shares derived: average of 2 quarters · filed 2024-11-07 | 10.23M shares 10-Q · filed 2024-11-07 | 102.35M shares 10-Q · filed 2023-11-09 | -16.00M shares derived: average of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | 10.92M shares 10-Q · filed 2024-08-13 | 109.21M shares 10-Q · filed 2023-08-11 | 9.86M shares 10-Q · filed 2024-08-13 | 98.61M shares 10-Q · filed 2023-08-11 | -24.99M shares derived: average of 3 quarters · filed 2024-08-13 | -9.60M shares derived: average of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | 8.79M shares 10-Q · filed 2024-05-14 | 88.16M shares 10-Q · filed 2023-05-12 | -42.95M shares derived: average of 2 quarters · filed 2024-05-14 | -16.44M shares derived: average of 3 quarters · filed 2024-05-14 | -3.23M shares derived: average of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | -94.68M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -29.06M shares derived: average of 2 quarters · filed 2024-03-05 | -7.24M shares derived: average of 3 quarters · filed 2024-03-05 | 3.65M shares 10-K · filed 2024-03-05 | 36.48M shares 10-K · filed 2023-03-08 | ||||
| 2022-09-30 | 36.57M shares 10-Q · filed 2023-11-09 | 36.48M shares derived: average of 2 quarters · filed 2023-11-09 | 36.42M shares 10-Q · filed 2023-11-09 | 36.44M shares derived: average of 4 quarters · filed 2023-11-09 | |||||
| 2022-06-30 | 36.40M shares 10-Q · filed 2023-08-11 | 36.35M shares 10-Q · filed 2023-08-11 | 36.40M shares derived: average of 3 quarters · filed 2023-08-11 | 28.54M shares derived: average of 4 quarters · filed 2023-08-11 | |||||
| 2022-03-31 | 36.31M shares 10-Q · filed 2023-05-12 | 36.40M shares derived: average of 2 quarters · filed 2023-05-12 | 25.92M shares derived: average of 3 quarters · filed 2023-05-12 | ||||||
| 2021-12-31 | 36.49M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | 20.73M shares derived: average of 2 quarters · filed 2023-03-08 | 11.39M shares 10-K · filed 2023-03-08 | ||||||
| 2021-09-30 | 4.97M shares 10-Q · filed 2022-11-10 | 3.03M shares 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |